Inventor · disambiguated record
Tianjian Li
Also filed as: LI TIANJIAN
7 granted patents·8 pending applications·31 citations·filing 2010–2021
82Inventor score
Top patents by PatentIndex Score
15 records- 0190US10150816B2Chimeric antigen receptorsCELGENE CORP·Filed 2013·Granted Dec 11, 2018·15 cites·10 claims
- 0289US11130820B2Chimeric antigen receptorsCELGENE CORP·Filed 2018·Granted Sep 28, 2021·4 cites·12 claims
- 0388US9121072B2Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsHOLMES MICHAEL C·Filed 2011·Granted Sep 1, 2015·5 cites·17 claims
- 0488US9115409B2Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsSANGAMO BIOSCIENCES INC·Filed 2013·Granted Aug 25, 2015·4 cites·15 claims
- 0578US10238690B2Modified T lymphocytes comprising an inducible caspase and methods of apoptosisCELGENE CORP·Filed 2014·Granted Mar 26, 2019·3 cites·12 claims
- 0670US11806365B2Modified T lymphocytes comprising a CD52 antibody-inducible caspase and methods of apoptosisCELGENE CORP·Filed 2021·Granted Nov 7, 2023·0 cites·20 claims
- 0770US10967005B2Modified T lymphocytes comprising a BAFF antibody-inducible caspase and methods of apoptosisCELGENE CORP·Filed 2019·Granted Apr 6, 2021·0 cites·18 claims
- 0868US2022348875A1Genetically modified natural killer cellsCELULARITY INC·Filed 2021·Application pending·0 cites
- 0968US2022106404A1Chimeric antigen receptorsCELGENE CORP·Filed 2021·Application pending·0 cites
- 1060US2021254003A1Car-t lymphocytes engineered to home to lymph node b cell zone, skin, or gastrointestinal tractCELGENE CORP·Filed 2020·Application pending·0 cites
- 1157US2011244474A1Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsSANGAMO BIOSCIENCES INC·Filed 2011·Application pending·0 cites
- 1255US2011014616A1Rapid screening of biologically active nucleases and isolation of nuclease-modified cellsSANGAMO BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 1353US2018273903A1Genetically modified natural killer cellsCELULARITY INC·Filed 2017·Application pending·0 cites
- 1451US2022118014A1Placenta-derived allogeneic car-t cells and uses thereofCELULARITY INC·Filed 2019·Application pending·0 cites
- 1547US2018080008A1Car-t lymphocytes engineered to home to lymph node b cell zone, skin, or gastrointestinal tractANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tianjian Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →